retatrutide phase 2 obesity trial results This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor Agonist for — A https://t.co/jNL1GNnHPT #Endocrinology VisualAbstract: Retatrutide reduces body weight

Only 5 patients stopped the trial from gastrointestinal side effects and only 5% of the 9mg and 12mg arms had to stop the trial for any adverse events

In this blog, we explore the evidence behind GLP-1 mental health side effects, how weight loss medications may alter your mood, and what to do if you are facing unpleasant psychological side effects

Researchers aimed to examine the efficacy, body fat reduction, and safety of this triple-hormone agonist across a broad patient population

i.e., the prescription is listed in mg/ml, and the syringe gradations match the prescription

T., Flavius, M., Rosca, A., Constantin, C., Scurtu, A., Moriczi, R., & Muresan, M

Golnesa GG Gharachedaghi In June 2023, the "Shahs of Sunset" star told her social media followers that she'd lost more weight than she intended to while taking Ozempic